Schrodinger, Inc.

SDGR · Healthcare

$20.84

Capitalización: 1.56B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Schrodinger, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Zacks3 sept 2026, 14:32

Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?

CNW Group3 sept 2026, 12:55

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Business Wire1 sept 2026, 12:30

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Zacks18 ago 2026, 7:43

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

Zacks17 ago 2026, 13:56

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma